Cargando…
Talimogene laherparepvec induces durable response of regionally advanced Merkel cell carcinoma in 4 consecutive patients
Autores principales: | Westbrook, Brian C., Norwood, T. Graham, Terry, Nina L.J., McKee, Svetlana B., Conry, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728723/ https://www.ncbi.nlm.nih.gov/pubmed/31516997 http://dx.doi.org/10.1016/j.jdcr.2019.06.034 |
Ejemplares similares
-
Talimogene laherparepvec: First in class oncolytic virotherapy
por: Conry, Robert M., et al.
Publicado: (2018) -
Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases
por: Blackmon, Jonathan T., et al.
Publicado: (2017) -
Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec
por: Blackmon, Jonathan T., et al.
Publicado: (2017) -
Durable melanoma control following disseminated talimogene laherparepvec herpetic infection
por: Shmuylovich, Leonid, et al.
Publicado: (2022) -
Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec
por: Singh, Neha, et al.
Publicado: (2023)